Business
Nanalysis Scientific Corp. (f. Canvass Ventures Ltd. ) Corporate Update, Q2 2019 Sales and Board Change
Nanalysis Scientific Corp. (f. Canvass Ventures Ltd. ) Corporate Update, Q2 2019 Sales and...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n\n\n\nNanalysis Scientific Corp. (f. Canvass Ventures Ltd. ) Corporate Update, Q2 2019 Sales and Board Change\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, July 17, 2019\n\n\n\nVANCOUVER, July 17, 2019 /CNW/ - Nanalysis Scientific Corp. (formerly Canvass Ventures Ltd.) \") (TSX Venture Exchange NSCI) (the \"Exchange\") is pleased to provide an inaugural post listing update and first official press release as a public company. \n\n \n \n\n \nCompletion of QT PP and Public Listing\nOn June 4, 2019 Nanalysis Scientific Corp. (Nanalysis or the Company) became a public company by completing an amalgamation with Canvass Ventures Ltd., a CPC, which constituted its Qualifying Transaction and joined the Tier 1 of the Exchange as a Technology/Industrial issuer. Nanalysis is the global leader in portable \"MRI-for-industry\" applications, with its proprietary magnetic resonance analyzers sold to pharmaceutical customers and into other market segments.\nConcurrently with the closing of the Qualifying Transaction, the Company raised $6.5 million in two private placements at $0.60 per share (see capitalization table below), with such shares subject to a four-month hold. This financing included a $1.5 million investment from the Chairman of the Natural Factors Group, a leading nutraceuticals manufacturer, which intends to promote Nanalysis' products throughout its extensive global network. The Company's shares began trading on the TSXV on June 13, 2019.\nFinancial and Sales Update\nNanalysis has a December 31st year end. W...